Clinical Decision Support

February 16, 2022 – Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, has announced completion of enrollment in the BIOADAPTOR randomized controlled trial (RCT). The ...

On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School of Medicine has been designated a qualified provider-led entity (qPLE). This allows Johns Hopkins to develop criteria that meet the requirements of the federal Protecting Access to Medicare Act (PAMA) of 2014 when ordering diagnostic imaging tests such as computed tomography (CT) scans, magnetic resonance imaging (MRI) scans and nuclear imaging in the emergency department and ambulatory settings.

A new set of appropriate use criteria (AUC) released Dec. 17 by a group of cardiovascular professional societies provide guidelines for peripheral artery interventions. The purpose of the AUC is to provide guidance to clinicians who may refer patients for revascularization treatments and to interventionalists and surgeons themselves. With the field of peripheral artery disease constantly evolving, it is imperative to offer tools and resources that physicians can utilize to provide the best care for their patients.

February 14, 2018 — The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact application, the first artificial intelligence (AI)-based clinical decision support ...